Expression of pituitary adenylate cyclase-activating polypeptide (PACAP), a neuropeptide with considerable homology to vasoactive intestinal peptide, has been shown to be stimulated by gonadotropins in the ovary. The present studies further evaluated the cell-type specific expression and gonadotropin regulation of PACAP type I receptor (PACAPR) messenger RNA in immature rat ovaries and in cultured preovulatory follicles. Northern blot analysis of ovaries obtained from prepubertal rats revealed the increased expression of PACAPR during prepubertal development. The major cell types expressing PACAPR messenger RNA were granulosa cells of large preantral follicles. Treatment of immature rats with PMSG caused a decrease in ovarian PACAPR expression. In contrast, treatment with human (h) CG at 2 days after PMSG treatment stimulated ovarian PACAPR messenger RNA within 3-6 h in granulosa cells of preovulatory follicles. Treatment of cultured preovulatory follicles in vitro with LH further confirmed the time-and dose-dependent stimulation of PACAPR by gonadotropins in granulosa cells of preovulatory follicles. Moreover, RNase protection assay revealed that the short variant of ovarian PACAPR was the predominant form stimulated during prepubertal development and by gonadotropins. These results demonstrate the expression of PACAPR messenger RNA in granulosa cells of growing follicles and of preovulatory follicles stimulated by gonadotropins, and suggest that PACAP may play a role in the growth of developing follicles and in ovulation as an autocrine/paracrine factor. (Endocrinology 141: [702][703][704][705][706][707][708][709] 2000) 
human (h) CG at 2 days after PMSG treatment stimulated ovarian PACAPR messenger RNA within 3-6 h in granulosa cells of preovulatory follicles. Treatment of cultured preovulatory follicles in vitro with LH further confirmed the time-and dose-dependent stimulation of PACAPR by gonadotropins in granulosa cells of preovulatory follicles. Moreover, RNase protection assay revealed that the short variant of ovarian PACAPR was the predominant form stimulated during prepubertal development and by gonadotropins. These results demonstrate the expression of PACAPR messenger RNA in granulosa cells of growing follicles and of preovulatory follicles stimulated by gonadotropins, and suggest that PACAP may play a role in the growth of developing follicles and in ovulation as an autocrine/paracrine factor. (Endocrinology 141: 702-709, 2000) P ITUITARY adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide isolated from ovine hypothalamus and exists in two amidated forms, PACAP-38 and PACAP-27, sharing the same N-terminal 27 amino acids (1) . On the basis of sequence similarity, PACAP belongs to the vasoactive intestinal peptide (VIP)/secretin/glucagon/GHreleasing factor family of neuropeptides (2) . Both forms of PACAP stimulate adenylate cyclase with high potency (1000-fold greater than VIP) in rat anterior pituitary cells (1) . In addition to the central and peripheral nervous system, the two molecular forms of PACAP exhibit a broad distribution and range of tissue concentrations (3, 4) . PACAP possesses a diverse array of biological activities consistent with its suggested role as a hypophysiotropic hormone, neurotransmitter and vasoregulator (3, 5) . PACAP has also been shown to be involved in spermatogenesis (6) and ovarian folliculogenesis (7) (8) (9) .
The biological effects of PACAP are mediated through PACAP binding to at least three types of G protein-coupled seven transmembrane PACAP receptors. Type I PACAP receptors (PACAPR) have high affinity only for PACAP and type II PACAP receptors have high affinity for both PACAP and VIP, which is also known as the VIP receptor (VIPR) (10, 11) . Spengler et al. (12) have identified five splice variants of the rat PACAPR differing only in their predicted third intracellular domains. The short variant form is designated PACAPR with the longer variant forms designated as hip, hop1, hop2, or hip-hop1 isoforms of the PACAPR. The splicing of the PACAPR gene has been shown to be differentially regulated in adult tissues (12) . It has also been demonstrated that both PACAP-27 and -38 stimulate adenylate cyclase, whereas only PACAP-38 stimulates phospholipase C with high potency due to the existence of splice variant in extracellular domain of PACAPR (13) . A third type of receptor (PACAPR-3) has recently been cloned in mice which binds PACAP and VIP with equal affinity (14) . This PACAPR-3 displays high affinity helodermin, but not secretin, binding, whereas VIPR binds helodermin and secretin with lower affinities than for PACAP/VIP (14) .
The PACAPR is expressed not only in the central nervous system but also in various peripheral tissues such as adrenal (12) , testis (15) , and ovary (16, 17) , whereas the VIPR is predominant in the lung, liver, and gastrointestinal tract (11) . Studies on the functional role of PACAP in steroidogenesis and oocyte maturation have suggested the presence of PACAP receptors in the ovary (7) (8) (9) 18) . Furthermore, binding sites for PACAP have been demonstrated in cyclic rat ovaries (19) . Although recent studies using the techniques of RT and PCR have shown the expression of messenger RNA (mRNA) encoding PACAPR in ovarian cells (16, 17) , cell-type specific localization and hormonal regulation of PACAPR in the ovary have not been reported. The present study was therefore designed to investigate the tissue localization and gonadotropin regulation of PACAPR gene expression during follicle growth in the rat ovary. We report here the stage-specific expression and gonadotropin induction of PACAPR mRNA in granulosa cells during ovarian follicle growth. We also demonstrated that the short variant form of PACAPR was predominant in the ovary.
Materials and Methods

Hormones and animals
Ovine LH (LH-S-26; 2,300 IU/mg) was obtained from the National Hormone and Pituitary Distribution Program, NIDDK, NIH (Baltimore, M.D.). hCG and PMSG were purchased from Sigma (St. Louis, MO).
Immature female rats of the Sprague Dawley strain were purchased from Daehan Laboratories (Chungbuk, Korea). They were housed in groups in a room with controlled temperature and photoperiod (10-h dark, 14-h light, with lights on from 0600 -2000 h). The animals had ad libitum access to food and water. The animals, ranging in age from 3-21 days, were killed by cervical dislocation, and the ovaries were removed for RNA analysis. Ovaries were also collected from immature (26-dayold) rats at various times after treatment with 10 IU PMSG to induce multiple follicle growth. Some rats received a single ip injection of 10-IU hCG to induce ovulation, and ovaries were obtained at different time intervals for Northern blot and in situ hybridization analysis.
Northern blot analysis
Total RNA from ovaries or cultured follicles was isolated using Tri Reagent solution (Sigma). Twenty micrograms of total RNA were fractionated by electrophoresis on a 1% agarose gel containing formaldehyde and transferred to nylon membranes by capillary blotting with 10 ϫ sodium citrate-sodium chloride (SSC). After a UV cross-linking and prehybridization, membranes were hybridized overnight at 42 C in a solution containing 50% formamide, 5 ϫ SSC, 1 mm EDTA, 250 g/ml denatured salmon sperm DNA, 500 g/ml yeast transfer RNA, and a total of 1 ϫ 10 7 cpm of a 32 P-labeled rat PACAPR complementary DNA (cDNA) probe (20) . After hybridization, membranes were washed twice for 5 min at room temperature in 2 ϫ SSC and 0.1 SDS, followed by 1 h at 65 C in 0.5 ϫ SSC and 0.1% SDS. Membranes were then exposed using Kodak RX films (Eastman Kodak Co., Rochester, NY) for 7-10 days at Ϫ80 C. The band intensities were subsequently measured using a phosphorimager (Bio-Rad Laboratories, Inc. Hercules, CA), and the signals were normalized to the 28S ribosomal RNA internal control.
FIG. 1.
Developmental expression of rat ovarian PACAPR gene. A, Aliquots of total RNA (20 g) isolated from ovaries on the indicated postnatal days were assayed for PACAPR mRNA levels by Northern blotting using a rat PACAPR cDNA probe. The estimated size (7 kb) of PACAPR transcript is indicated. The expression of 28S ribosomal RNA was used as an internal standard. Hyp, Hypothalamus. B, Quantitative estimation of ovarian PACAPR mRNA levels during development. The 7-kb PACAPR transcript was quantified using a phosphorimager and normalized for 28S ribosomal RNA levels in each sample. Results are expressed relative to ovarian PACAPR mRNA levels found at 3 days of age. Each data point represents the mean Ϯ SEM from four independently performed experiments. 
In situ hybridization analysis
Ovaries or cultured follicles were fixed at 4 C for 6 h in 4% paraformaldehyde in PBS, followed by immersion in 0.5 m sucrose in PBS overnight. Cryostat sections (14-m thick) were mounted on poly-llysine (Sigma)-coated microscope slides, fixed in 4% paraformaldehyde in PBS, and stored at Ϫ80 C until analyzed. The hybridization procedure was essentially the same as previously described (9) . In brief, sections were pretreated serially with 0.2 m HCl, 2 ϫ SSC, pronase (0.125 mg/ml), 4% paraformaldehyde, and acetic anhydride in triethanolamine. Hybridization was carried out at 52Ϫ55 C overnight in the mixture containing 35 S-labeled rat PACAPR complementary RNA (cRNA) probe (2 ϫ 10 8 cpm/ml), 50% formamide, 0.3 m NaCl, 10 mm Tris-HCl, 5 mm EDTA, 1 ϫ Denhardt's solution, 10% dextran sulfate, 1 g/ml carrier transfer RNA, and 10 mm dithiothreitol. Posthybridization washing was performed under stringent conditions that included ribonuclease A (25 g/ml) treatment at 37 C for 30 min and a final stringency of 0.1 ϫ SSC. Slides were dipped into NTB-2 emulsion (Eastman Kodak Co.) and exposed at 4 C and developed after 3-4 weeks. The slides were stained with hematoxylin and eosin and examined under the light microscope with bright-and dark-field illumination.
Follicle culture
Preovulatory follicles (Ͼ800 m in diameter) were dissected by fine forceps from ovaries collected at 48 -52 h after PMSG injection, and follicle culture was performed as previously described (9) . Fifteen to twenty follicles were cultured in glass vials containing 800 l MEM (Life Technologies, Inc., Grand Island, NY) supplemented with penicillin, streptomycin, l-glutamine, and 0.1% BSA (wt/vol, Fraction V, Sigma) in the absence or presence of LH. Cultures were maintained for up to 24 h at 37 C under 5% CO 2 -95% O 2. Following incubation, follicles were snap-frozen for RNA isolation, or were fixed for in situ hybridization analysis.
RNase protection assay
For the detection of the expression of different PACAPR variants in the ovary, RNase protection assay (RPA) was performed using RPA II Kit (Ambion, Inc., Austin, TX) with cRNA probe encompassing the splice site of PACAPR (nucleotides 793-1143) (12) . The expected bands after RNase digestion include 351 bp for the short variant form and 248/103 bp for other longer variant forms. Run-off transcripts were synthesized from each linearized template using a Transcription in vitro System Kit (Promega Corp., Madison, WI). The full-length singlestranded RNA probes were purified by acrylamide gel electrophoresis. Twenty to thirty micrograms of ovarian total RNA were hybridized with 32 P-labeled rat PACAPR and rat glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) cRNA probes at 43 C overnight. After hybridization
Changes in PACAPR mRNA levels in ovaries of PMSG/hCGtreated immature rats. A, Aliquots of total RNA (20 g) isolated from ovaries at the indicated time intervals after PMSG/hCG stimulation were assayed for PACAPR mRNA levels by Northern blotting using a rat PACAPR cDNA probe. The estimated size (7 kb) of PACAPR transcript is indicated. The expression of 28S ribosomal RNA was used as an internal standard. B, Quantitative estimation of ovarian PACAPR mRNA levels during gonadotropin stimulation. The 7-kb PACAPR transcript was quantified using a phosphorimager and normalized for 28S ribosomal RNA levels in each sample. Results are expressed relative to ovarian PACAPR mRNA levels found at 0 h and 48 h after PMSG treatment for PMSG-treated and PMSG/hCGtreated rat ovaries, respectively. Each data point represents the mean Ϯ SEM from three to four independently performed experiments. samples were digested with RNase A and T1 before precipitation and electrophoresis on a 5% denaturing polyacrylamide gel. After electrophoresis, gels were exposed to the Kodak RX films for 48 -72 h at Ϫ80 C. The band intensities were subsequently measured using a phosphorimager (Bio-Rad Laboratories, Inc.), and the signals were normalized to the GAPDH internal control.
Results
Ovarian PACAPR gene expression during development
The developmental changes in PACAPR mRNA levels in the ovary were determined by a Northern blot analysis. As shown in Fig. 1A , the 7-kb transcript was detected in the ovary as well as in the hypothalamus. The ovarian PACAPR transcript was visible in 3-day-old rats and markedly increased in 21-day-old rats. The levels of ovarian PACAPR expression were 2.2-fold higher in 21-day-old rats than in 15-day-old rats (Fig. 1B) . To determine the site of PACAPR mRNA expression, in situ hybridization was performed on ovarian sections obtained from 21-day-old rats. PACAPR mRNA was detected in growing follicles of immature rat ovaries (Fig. 2) . High levels of PACAPR mRNA were mainly detected in large preantral follicles (PAF) (Fig. 2, A and B) . Some small preantral follicles also expressed PACAPR mRNA (Fig. 2, A and B) . Under higher magnification, the PACAPR signal was shown to be restricted to the granulosa cells (Gc) of preantral follicles (Fig. 2C) . However, atretic follicles (AtF) and mural granulosa cells of early antral follicles (EAF) were devoid of PACAPR mRNA (Fig. 2, A and  B) . No specific signal was detected in ovarian sections hybridized with sense probe (Fig. 2D) .
Gonadotropin stimulation of PACAPR mRNA in preovulatory follicles
To characterize gonadotropin regulation of PACAPR expression in the ovary, total RNA extracted from ovaries at different times after gonadotropin treatments was analyzed by Northern blotting. As shown in Fig. 3A , PMSG treatment of 26-day-old immature rats caused a gradual decrease in ovarian PACAPR expression. Treatment with hCG of PMSGprimed rats, however, stimulated ovarian PACAPR expression within 3-6 h. The levels of PACAPR mRNA declined by 9 h after treatment. Quantitative analysis of ovarian PACAPR signals (Fig. 3B) showed a 55% decrease 48 h after PMSG and a 160% increase 6 h after hCG. To determine the cell types expressing PACAPR mRNA in gonadotropin-treated ovaries, antisense and sense cRNA probes for PACAPR were generated for in situ hybridization analysis. In ovaries obtained 2 days after PMSG treatment, PACAPR signals were detected in growing follicles, but not in preovulatory follicles (Fig. 4A) . In the ovaries of PMSG-primed immature rats, followed by hCG stimulation for 6 h, PACAPR mRNA was detected in preovulatory follicles as well as in growing follicles (Fig. 4B) . Under higher magnification, the PACAPR signal was shown to be defined in the granulosa cells of preovulatory follicles (Fig. 4C) . Ovarian sections hybridized with the sense PACAPR riboprobe showed only background hybridization (Fig. 4D) .
To study the hormonal regulation of PACAPR mRNA expression, preovulatory follicles obtained from ovaries of rats primed for 2 days with PMSG were incubated in serumfree condition. Northern blot analysis revealed that LH treatment resulted in the stimulation of PACAPR mRNA within 6 h which persisted at 9 h after the treatment and declined at 12 h in cultured preovulatory follicles (Fig. 5A, left panel) . Furthermore, LH treatment for 6 h stimulated PACAPR mRNA in a dose-dependent manner, reaching saturating levels at 100 ng/ml (Fig. 5A, right panel) . Quantitative analysis (Fig. 5B) showed that LH treatment resulted in 3.4-and 3.0-fold increase in follicular PACAPR mRNA by 6 h and 9 h, respectively. To determine the site of PACAPR mRNA expression in cultured preovulatory follicles, in situ hybridization was performed on sections of follicles incubated in the presence of LH for 6 h. PACAPR signals were detected in granulosa cells, but not theca cells (Fig. 6, A and B) . Under higher magnification, patchy signals of PACAPR mRNA were seen in the granulosa cells of preovulatory follicles (Fig.  6C) . Preovulatory follicles cultured in the absence of LH for 6 h did not express PACAPR mRNA (data not shown). No
FIG. 5. Stimulation of PACAPR mRNA expression by LH in preovulatory follicles cultured in vitro.
A, Preovulatory follicles, obtained from ovaries of PMSG-primed immature rats, were cultured in serumfree conditions under 5% CO 2 -95% O 2 at 37 C in the presence of LH. Total RNA was extracted from follicles collected at the indicated time intervals after LH (200 ng/ml) stimulation (left panel), or from follicles cultured in the absence (control; C) or presence of increasing doses of LH for 6 h (right panel). Twenty micrograms of follicular total RNA were then analyzed for PACAPR mRNA levels by Northern blotting using a rat PACAPR cDNA probe. The estimated size (7 kb) of PACAPR transcript is indicated. The expression of 28S ribosomal RNA was used as an internal standard. B, Quantitative estimation of follicular PACAPR mRNA levels after LH treatment. The 7-kb PACAPR transcript was quantified using a phosphorimager and normalized for 28S ribosomal RNA levels in each sample. Results are expressed relative to follicular PACAPR mRNA levels found at 0 h after LH treatment. Each data point represents the mean Ϯ SEM from three independently performed experiments.
specific signal was detected in follicles hybridized with sense probe (Fig. 6D) .
Predominant expression of the short variant form of PACAPR mRNA in the ovary
Five splice variant forms have been identified in PACAPR, the short variant and four other longer variants with insertions of hip (84 bp) or/and hop (84 bp) cassettes in the third intracellular loop (12) . To study the expression of the different PACAPR variants in the ovary, we performed RNase protection assay with cRNA probe encompassing the splice site. As depicted in Fig. 7A , the protected band of the short variant form (short; 351 bp) and other longer variant forms (hip/hop; 248 bp) of PACAPR were found to be present in ovaries of 15-day-old rats. However, only the expression of the short variant form was clearly increased in ovaries of 21-day-old rats. Furthermore, treatment of PMSG-primed rats with hCG resulted in the stimulation of the short variant form, but not longer variant forms. Similarly, inclusion of LH in the culture medium of preovulatory follicles caused upregulation of the short variant form of PACAPR. Both the short and longer variant forms of PACAPR were expressed in the brain which was used as a positive control (Fig. 7A) . Figure 7B graphically summarizes the quantitative densitometry results of these studies after normalization for glyceraldehyde-3phosphate dehydrogenase (GAPDH) mRNA levels. The levels of the short variant form of PACAPR were increased, on the average, 4.6-, 2.9-, and 5.1-fold in ovaries of 21-day-old rats, in PMSG/hCG-treated ovaries and in preovulatory follicles cultured in the presence of LH compared with the corresponding control levels, respectively. In contrast, the levels of the longer variant forms of PACAPR did not significantly vary with the age of rats or gonadotropin treatment.
Discussion
The present study shows a stage-specific expression and cell-specific localization of PACAPR in the rat ovary during both prepubertal development and gonadotropin-induced ovulation. We found that granulosa cells of the large preantral follicles were the major cell type expressing high levels of PACAPR mRNA, explaining the observation of the increased levels of ovarian PACAPR during prepubertal development. Furthermore, LH/hCG treatment caused transient stimulation of PACAPR gene expression in granulosa cells of preovulatory follicles. We also demonstrate that the short variant of ovarian PACAPR is the predominant form stimulated during prepubertal development and by gonadotropins.
PACAP can interact with specific receptors. The type I receptor (PACAPR) specifically binds PACAP, whereas type II receptor (VIPR) binds PACAP and VIP with similar affinity (21) . VIP-immunoreactive nerve fibers are detected in theca/ interstitial cells of the juvenile rat ovary (22) , and VIP has been shown to increase cAMP accumulation and steroidogenesis in cultured granulosa cells (23) . Although binding studies using whole ovaries have suggested the presence of VIPR in the rat ovary (19) , a recent paper demonstrates the expression of PACAPR mRNA in the ovary of adult cycling rats of undocumented cycle stage (16) . Furthermore, PACAP has been shown to be more potent than VIP in the stimulation of steroidogenesis and cAMP accumulation in cultured granulosa cells of large growing follicles obtained from estrogentreated immature rats (7, 8) , suggesting that these cells may contain PACAPR. The present study provides the direct evidence for the presence of PACAPR in granulosa cells of growing follicles. Our observations showing low levels of PACAPR expression in ovaries of prepubertal rats before 15 days of age and a marked increase at 21 days of age indicate that PACAPR expression is increased in a stage-specific man- ner during ovarian follicle growth. It has been shown that ovaries of rat before 15 days of age mainly contain nongrowing and small growing follicles (24) . The stage-specific expression of PACAPR is further supported by the fact that PMSG treatment caused time-dependent decrease in ovarian PACAPR expression. PMSG is a hormone known to stimulate a multiple growth of growing follicles to the preovulatory stage (25) . Of further interest are the present findings demonstrating the stimulation of PACAPR mRNA in granulosa cells of preovulatory follicles by LH/hCG. Support for our findings of gonadotropin stimulation of PACAPR in preovulatory follicles comes from a recent report showing that cotreatment with PACAP-38 and LH results in the higher production of progesterone and cAMP than treatment with PACAP-38 or LH alone in cultured granulosa cells obtained from rat preovulatory follicles (17) . Thus, the present findings suggest that the direct PACAPR-mediated actions of PACAP on ovarian function may be restricted to specific developmental windows.
Our previous study, demonstrating the gonadotropin induction of PACAP in granulosa cells of preovulatory follicles and in some theca/interstitial cells regardless of follicle size, has suggested a role of PACAP as an ovarian local regulator (9) . Data from the present study provide further evidence that PACAP may participate in the regulation of ovarian function. First, it may act as a mediator for LH action during ovulation. The LH surge is obligatory to induce the processes of follicle rupture and luteinization. Although the biochemical cascade that leads to ovulation is largely unknown, a number of specific genes associated with ovulation have been identified (26) . The rapid, but transient, increase in PG endoperoxide synthase (27) , tissue plasminogen activator (28) , and progesterone receptor (29) has been shown to play a role in LH-induced ovulation. The similar observation that LH induces a transient expression of both PACAP (9) and PACAPR in granulosa cells of preovulatory follicles raises the possibility that PACAP may be functionally associated with the process of follicle rupture and/or luteinization, acting as an autocrine regulator. Indeed, a recent report demonstrates an autocrine role for PACAP during gonadotropininduced periovulatory progesterone production and subsequent luteinization in the rat ovary (30) . Second, PACAP may have a role in the regulation of early folliculogenesis. It is known that ovarian follicular growth begins and proceeds to the late preantral stage independently of gonadotropin regulation (31) . Further development depends upon FSH acting upon its cognate receptor expressed by granulosa cells (32) . It has been suggested that insulin-like growth factor I, expressed in granulosa cells of healthy growing follicles, may promote follicle growth by augmenting granulosa cell FSH receptor responsiveness (33) , and thereby amplifying FSHinduced aromatase expression and LH receptor induction (34, 35) . Similarly, activin has been shown to promote folliculogenesis during the preantral or early antral stages of growth of follicles by amplifying granulosa cell responsiveness to FSH (36) . The present study demonstrating the major expression of PACAPR in granulosa cells of large preantral follicles indicates that PACAP may promote the growth of these preantral and early antral follicles. PACAP secreted from granulosa cells of preovulatory follicles and/or from theca cells of growing follicles after LH/hCG stimulation (9) may bind to its receptors present in granulosa cells of growing follicles, and hence may enhance granulosa cell responsiveness to FSH. This action of PACAP following LH surge in cyclic rats may be needed to stimulate follicle recruitment FIG. 7 . Expression of PACAPR variant gene in the rat ovary. A, Autoradiogram of RNase protection assay. Total RNA was extracted from ovaries of immature rats (Age), PMSG/hCG-treated rats (hCG) and from preovulatory follicles cultured in the presence of 200 ng/ml LH. Aliquots of total RNA (20 -30 g) were assayed using rat PACAPR and GAPDH cRNA probes as described in Materials and Methods. Protected bands corresponding to the short variant form (short; 351 bp) and other longer variant forms (hip/hop; 248 bp) of PACAPR mRNA and GAPDH mRNA (140 bp) are indicated. The numbers on the left indicate the positions of RNA size marker (M). The gels were exposed for 72 h at Ϫ80 C. A shorter exposure (48 h) for the protected fragments of the GAPDH RNA is also shown at the bottom. B, Quantitation of the bands corresponding to ovarian short variant form (short) and other longer variant forms (hip/hop) of PACAPR mRNAs. Hybridization signals were quantified with a phosphorimager and normalized for GAPDH mRNA levels in each sample. Data were expressed relative to the levels of hip/hop variant mRNAs found at 15 days of age, 0 h after PMSG/hCG or LH treatment. Each data point represents the mean Ϯ SEM from two independently performed experiments.
for the subsequent cycle by enhancing the effect of a secondary surge of FSH on the day of estrus, which has been suggested to play a role in follicular recruitment (37) . Transient induction of PACAP after the LH surge has also been demonstrated in cyclic rats (38) . Studies are currently underway to examine these possibilities for the role of PACAP in the process of ovulation and in the promotion of growth of growing follicles.
Five splice variants of the PACAPR with different pattern of signal transduction have been identified in the rat (12) . The short PACAPR (without hip/hop cassette) as well as the PACAPR hop variants potently activate both adenylate cyclase and phospholipase C, whereas the PACAPR hip and hip-hop variants display a deficient or altered ability to activate phospholipase C. Moreover, the splicing of the PACAPR gene is differentially regulated in adult tissues. The short PACAPR is the most abundant form in the brain, whereas PACAPR hop predominates in the testes, olfactory bulb, and adrenal gland (12) . The present study demonstrates that the short PACAPR was the predominant form stimulated during prepubertal development and by LH/ hCG during ovarian follicle growth. The expression of PACAPR splice variants in adult rat ovary has also been identified by the techniques of RT and PCR (RT-PCR) (16) . Because splice variants of the PACAPR display differential signal transduction properties in the same cell type (12), the expression of different variants of PACAPR may subserve distinct patterns of signal transduction activated by PACAP during ovarian follicle growth. Further studies are necessary to ascertain whether the expression of the short PACAPR variant is physiologically important in the ovary during prepubertal development and gonadotropin-induced ovulation.
In summary, the present study has demonstrated that PACAPR gene is expressed in the rat ovary in a stage-and cell-specific manner during follicle development. The increased expression of PACAPR, mainly the short variant form, is restricted to granulosa cells of the growing follicles during prepubertal development and to granulosa cells of preovulatory follicles after gonadotropin stimulation. Further studies are needed to determine whether PACAP is involved in the regulation of early follicle growth and ovulation during follicle development.
